Sign in

CIK 0000727510

  • Non-accelerated filer
  • Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222372868
Phone
+1 630-874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Executive VP, COO, PEO, CFO acquired 45,000 shares (grant or award)
  5. 4 Open-market sale VP and General Counsel sold 3,766 shares at $6.68 ($25,157)
  6. 4 Open-market sale VP, Clinical Development sold 2,700 shares at $7.06 ($19,062)
  7. 4 Shares withheld for taxes VP, Research gave up 591 shares (to pay taxes)
  8. 4 Shares withheld for taxes COO and Princ. Exec. Officer gave up 886 shares (to pay taxes)
  9. 4 Shares withheld for taxes VP and General Counsel gave up 2,067 shares (to pay taxes)
  10. 4 Shares withheld for taxes VP, Clinical Development gave up 2,952 shares (to pay taxes)
  11. 4 Grant or award VP, Clinical Development acquired 8,000 shares (grant or award)
  12. 4 Grant or award VP and General Counsel acquired 10,000 shares (grant or award)
  13. 4 Grant or award COO and Princ. Exec. Officer acquired 35,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 14,764 shares (grant or award)
  18. 4 Grant or award Director acquired 7,382 shares (grant or award)
  19. 4 Grant or award Director acquired 12,919 shares (grant or award)
  20. 4 Grant or award Director acquired 7,382 shares (grant or award)

Page 5 of 28 · 560 filings